Grantham, Mayo, Van Otterloo & Co (GMO)’s Amrize Ltd AMRZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.9M Buy
73,170
+64,380
+732% +$3.49M 0.01% 358
2026
Q1
$492K Buy
+8,790
New +$504K ﹤0.01% 556
2025
Q3
Sell
-26,766
Closed -$1.33M 665
2025
Q2
$1.33M Buy
+26,766
New +$1.35M ﹤0.01% 410

Other funds holding AMRZ

Grantham, Mayo, Van Otterloo & Co (GMO)'s AMRZ Position: Q2 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) increased its Amrize Ltd (AMRZ) stake by 732% in Q2 2026, buying an estimated $3.49M and bringing the position to 73,170 shares worth $3.9M. The position accounts for 0.01% of the portfolio, ranked #358.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in AMRZ in Q2 2025 and has held it in 3 quarters since. 464 funds tracked by Wall St. Rank hold AMRZ as of Q2 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 73,170 shares of Amrize Ltd worth $3.9M as of Q2 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) bought 64,380 Amrize Ltd shares in Q2 2026, an estimated $3.49M.
  • Amrize Ltd made up 0.01% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q2 2026, its #358 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Amrize Ltd in Q2 2025 and has held it in 3 quarters since.
  • 464 funds tracked by Wall St. Rank held Amrize Ltd as of Q2 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.